Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The primary objective of the study is to determine the safety of oral ifetroban compared to placebo as measured by a \> 20% decrease in FEV1 compared to baseline following a dose of Investigational Medicinal Product (IMP) (Study Day 1 or 2) prior to initiation of the aspirin challenge.
Epistemonikos ID: 753db293179e28afd859b1148e568f39b5daa038
First added on: May 12, 2024